Nanostructure lipid preparation for improving doxorubicin tumor active targeting and kidney protection and preparation method
A nanostructured lipid, active targeting technology, applied in antitumor drugs, medical preparations with non-active ingredients, and medical preparations containing active ingredients, etc., can solve the problems of high nephrotoxicity and poor tumor targeting, etc. Achieve uniform particle size and strong tumor targeting effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] A method for preparing a nanostructured lipid preparation for improving active tumor targeting and renal protection of doxorubicin, comprising the following steps:
[0047] (1) Take salvianolic acid A, doxorubicin hydrochloride and Maize 52 in the ratio of 5:3:300:5000 by mass ratio, dissolve them in deionized water, and make the water phase;
[0048] Take soybean lecithin and distearoyl phosphatidylethanolamine-polyethylene glycol-E-[c(RGDfK) in the ratio of 50:3:1000 by mass ratio 2 ], be dissolved in dehydrated alcohol, make the first solution;
[0049] Take glyceryl behenate and distearoylphosphatidylethanolamine-polyethylene glycol-folic acid in a mass ratio of 30:3:500, and dissolve them in chloroform to make a second solution:
[0050] The volume ratio is 10:1, the first solution and the second solution are combined and stirred evenly to make an oil phase;
[0051] (2) The oil phase is dropped into the water phase, then, the organic solvent is removed by heatin...
Embodiment 2
[0055] A method for preparing a nanostructured lipid preparation for improving active tumor targeting and renal protection of doxorubicin, comprising the following steps:
[0056] (1) Take salvianolic acid A, doxorubicin hydrochloride and poloxamer in a mass ratio of 1:1:100:5000, dissolve them in deionized water, and make an aqueous phase;
[0057] Take dioleoylphosphatidylethanolamine and distearoylphosphatidylethanolamine-polyethylene glycol-E-[c(RGDfK) in a ratio of 20:1:1000 by mass ratio 2 ], be dissolved in dehydrated alcohol, make the first solution;
[0058] Take isopropyl palmitate and distearoylphosphatidylethanolamine-polyethylene glycol-folic acid in a mass ratio of 10:1:500, and dissolve them in chloroform-dimethylsulfoxide (volume ratio 1:1) , making the second solution:
[0059] The volume ratio is 5:1, the first solution and the second solution are combined and stirred evenly to make an oil phase;
[0060] (2) Drop the oil phase into the water phase, then h...
Embodiment 3
[0064] A method for preparing a nanostructured lipid preparation for improving active tumor targeting and renal protection of doxorubicin, comprising the following steps:
[0065] (1) Get salvianolic acid A, doxorubicin hydrochloride and sodium cholate in the ratio of 10:5:500:5000 by mass ratio, dissolve them in deionized water, and make the water phase;
[0066] Take dimyristoylphosphatidylglycerol and distearoylphosphatidylethanolamine-polyethylene glycol-E-[c(RGDfK) in a mass ratio of 100:5:1000 2 ], be dissolved in absolute ethanol-dimethyl sulfoxide (volume ratio 1:1), make the first solution;
[0067] Take glyceryl laurate and distearoylphosphatidylethanolamine-polyethylene glycol-folic acid in a mass ratio of 50:5:500, and dissolve them in dimethyl sulfoxide to make a second solution:
[0068] The volume ratio is 15:1, the first solution and the second solution are combined and stirred evenly to make an oil phase;
[0069] (2) Drop the oil phase into the water phase,...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com